上皮-间质转换
胰腺癌
癌症
类有机物
癌相关成纤维细胞
癌症研究
生物
医学
癌细胞
细胞
肿瘤微环境
间充质干细胞
病理
细胞生物学
转移
肿瘤细胞
遗传学
作者
Samantha Guinn,Benedict Kinny‐Köster,Joseph A. Tandurella,Jacob T. Mitchell,Dimitrios N. Sidiropoulos,Melanie Loth,Melissa R. Lyman,Alexandra B. Pucsek,Daniel J. Zabransky,Jae W. Lee,Emma Kartalia,Mili Ramani,Toni T. Seppälä,Christopher Cherry,Reecha Suri,Haley Zlomke,Jignasha Patel,Jin He,Christopher L. Wolfgang,Jun Yu
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2024-04-08
卷期号:84 (9): 1517-1533
被引量:7
标识
DOI:10.1158/0008-5472.can-23-1660
摘要
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by an immunosuppressive tumor microenvironment enriched with cancer-associated fibroblasts (CAF). This study used a convergence approach to identify tumor cell and CAF interactions through the integration of single-cell data from human tumors with human organoid coculture experiments. Analysis of a comprehensive atlas of PDAC single-cell RNA sequencing data indicated that CAF density is associated with increased inflammation and epithelial–mesenchymal transition (EMT) in epithelial cells. Transfer learning using transcriptional data from patient-derived organoid and CAF cocultures provided in silico validation of CAF induction of inflammatory and EMT epithelial cell states. Further experimental validation in cocultures demonstrated integrin beta 1 (ITGB1) and vascular endothelial factor A (VEGFA) interactions with neuropilin-1 mediating CAF-epithelial cell cross-talk. Together, this study introduces transfer learning from human single-cell data to organoid coculture analyses for experimental validation of discoveries of cell–cell cross-talk and identifies fibroblast-mediated regulation of EMT and inflammation. Significance: Adaptation of transfer learning to relate human single-cell RNA sequencing data to organoid-CAF cocultures facilitates discovery of human pancreatic cancer intercellular interactions and uncovers cross-talk between CAFs and tumor cells through VEGFA and ITGB1.
科研通智能强力驱动
Strongly Powered by AbleSci AI